首页> 美国卫生研究院文献>Clinical and Translational Medicine >Long noncoding RNA IL6‐AS1 is highly expressed in chronic obstructive pulmonary disease and is associated with interleukin 6 by targeting miR‐149‐5p and early B‐cell factor 1
【2h】

Long noncoding RNA IL6‐AS1 is highly expressed in chronic obstructive pulmonary disease and is associated with interleukin 6 by targeting miR‐149‐5p and early B‐cell factor 1

机译:长度非致RNA IL6-AS1在慢性阻塞性肺疾病中高度表达通过靶向miR-149-5P和早期B细胞因子1与白细胞介素6相关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic obstructive pulmonary disease is a complex condition with multiple etiologies, including inflammation. We identified a novel long noncoding RNA (lncRNA), interleukin 6 antisense RNA 1 (IL6‐AS1), which is upregulated in this disease and is associated with airway inflammation. We found that IL6‐AS1 promotes the expression of inflammatory factors, especially interleukin (IL) 6. Mechanistically, cytoplasmic IL6‐AS1 acts as an endogenous sponge by competitively binding to the microRNA miR‐149‐5p to stabilize IL‐6 mRNA. Nuclear IL6‐AS1 promotes IL‐6 transcription by recruiting early B‐cell factor 1 to the IL‐6 promoter, which increases the methylation of the H3K4 histone and acetylation of the H3K27 histone. We propose a model of lncRNA expression in both the nucleus and cytoplasm that exerts similar effects through differing mechanisms, and IL6‐AS1 probably increases inflammation via multiple pathways.
机译:慢性阻塞性肺病是一种复杂的病症,具有多种病因,包括炎症。我们鉴定了一种新型的长度非典型RNA(LNCRNA),白细胞介素6反义RNA 1(IL6-AS1),其在该疾病中上调,与气道炎症有关。我们发现IL6-AS1促进炎症因子的表达,特别是白细胞介素(IL)6。机械地,通过竞争性地结合MicroRNA miR-149-5p以稳定IL-6 mRNA来充当内源海绵的细胞质IL6-AS1。核IL6-AS1通过募集早期B细胞因子1至IL-6启动子来促进IL-6转录,这增加了H3K4组蛋白和H3K27组蛋白的甲基化的甲基化。我们提出了一种在核和细胞质中的LNCRNA表达模型,通过不同的机制施加类似的效果,IL6-AS1可能通过多种途径增加炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号